Literature DB >> 1728540

Insulin-like growth factors in lysosomal storage disease.

S E Jaeggi-Groisman1, W Kiess, H Christomanou, U Kessler, E R Froesch.   

Abstract

Recent data indicate that insulin-like growth factor II (IGF II) and lysosomal enzymes bind to a common receptor. We measured serum IGF I and II levels in 16 patients with various lysosomal storage disorders. The IGF serum concentrations were normal as long as no marked liver disease was present. Under these conditions no direct interconnection between the lysosomal system and the serum IGF levels was found.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1728540     DOI： 10.1007/bf02073885

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  12 in total

Review 1.  Mannose 6-phosphate receptors and lysosomal enzyme targeting.

Authors:  N M Dahms; P Lobel; S Kornfeld
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

Review 2.  The nature and regulation of the receptors for insulin-like growth factors.

Authors:  M M Rechler; S P Nissley
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

3.  Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.

Authors:  W Kiess; G D Blickenstaff; M M Sklar; C L Thomas; S P Nissley; G G Sahagian
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

4.  The cation-independent mannose 6-phosphate receptor binds insulin-like growth factor II.

Authors:  P Y Tong; S E Tollefsen; S Kornfeld
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

5.  Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats.

Authors:  J Zapf; C Hauri; M Waldvogel; E Futo; H Häsler; K Binz; H P Guler; C Schmid; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Insulin-like growth factor-II (IGF-II) inhibits both the cellular uptake of beta-galactosidase and the binding of beta-galactosidase to purified IGF-II/mannose 6-phosphate receptor.

Authors:  W Kiess; C L Thomas; L A Greenstein; L Lee; M M Sklar; M M Rechler; G G Sahagian; S P Nissley
Journal:  J Biol Chem       Date:  1989-03-15       Impact factor: 5.157

7.  Serum insulin-like growth factor II in chronic liver disease.

Authors:  T Hayakawa; T Kondo; T Shibata; M Kitagawa; H Ono; Y Sakai; K Kato; N Katada; Y Sugimoto; M Takeichi
Journal:  Dig Dis Sci       Date:  1989-03       Impact factor: 3.199

8.  Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II?

Authors:  U Widmer; J Zapf; E R Froesch
Journal:  J Clin Endocrinol Metab       Date:  1982-11       Impact factor: 5.958

9.  Insulin-like growth factor II receptor as a multifunctional binding protein.

Authors:  D O Morgan; J C Edman; D N Standring; V A Fried; M C Smith; R A Roth; W J Rutter
Journal:  Nature       Date:  1987 Sep 24-30       Impact factor: 49.962

10.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; H Walter; E R Froesch
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.